We're sorry, but something went wrong while fetching your podcast feeds. Please contact us at [email protected] for help.

GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. But what does it feel like for the patients who take them?

On this week's episode of Well, Now Kavita and Maya talk with journalist and author Johann Hari. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. All the while, he was also taking Ozempic himself.

His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs takes a personal and research-based look at the revolutionary, controversial rise of GLP-1 drugs for weight management.

If you liked this episode, check out: The Full Truth About Ozempic and Doctors Agree: Obesity is a Disease. The Public Needs to Catch Up.

Well, Now is hosted by registered dietitian nutritionist Maya Feller and Dr. Kavita Patel.

Podcast production by Vic Whitley-Berry with editorial oversight by Alicia Montgomery.

Send your comments and recommendations on what to cover to [email protected]

Want to listen to Well, Now uninterrupted? Subscribe to Slate Plus to immediately unlock ad-free listening to Well, Now and all your other favorite Slate podcasts.

Subscribe now on Apple Podcasts by clicking "Try Free" at the top of our show page. Or, visit slate.com/wellplus to get access wherever you listen.